Home » Topics » BioWorld Science

BioWorld Science
RSS

SBIR grant supports Sentia's development of astressins for IBS

May 24, 2019

Synlogic enters collaboration with Roche to study SYNB-1891 with Tecentriq in advanced tumors

May 24, 2019

Bioimics identifies bacterial ribonuclease P inhibitors

May 24, 2019

FDA grants marketing authorization to Zika virus diagnostic test

May 24, 2019

U.S. researchers present ALDH1A1 inhibitors

May 24, 2019

GlaxoSmithKline identifies IDO1 inhibitors

May 24, 2019

Norovirus VLP vaccine TAK-214 immunogenic, well tolerated in phase II study

May 24, 2019

Amgen discloses APLNR agonists

May 24, 2019

ChemoCentryx divulges C5AR1 antagonists

May 24, 2019

GSK-2831781 begins phase II trial in moderate to severe active ulcerative colitis

May 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...